Related Experiment Video
Updated: May 10, 2026

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
The Role of Human Leukocyte Antigen Alleles and Maternal Microchimerism in Very-Early-Onset Ulcerative Colitis in
Masanori Toda1, Keisuke Jimbo2, Mitsuyoshi Suzuki2
1Department of Pediatrics, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Insights
Very-early-onset ulcerative colitis (VEO-UC) involves specific human leukocyte antigen (HLA) alleles and maternal microchimerism (MMc). These genetic and maternal immune factors contribute to VEO-UC pathogenesis in Japanese children.
Area of Science:
- Immunology
- Genetics
- Gastroenterology
Background:
- Very-early-onset ulcerative colitis (VEO-UC) is a severe form of inflammatory bowel disease presenting before age 6.
- VEO-UC exhibits distinct genetic and immunological characteristics compared to typical pediatric UC.
- Investigating human leukocyte antigen (HLA) alleles and maternal microchimerism (MMc) is crucial for understanding VEO-UC pathogenesis.
Purpose of the Study:
- To examine the association of specific HLA alleles with VEO-UC in a Japanese population.
- To investigate the presence and role of maternal microchimerism (MMc) in VEO-UC intestinal tissues.
- To elucidate the interplay of genetic and maternal immune factors in VEO-UC development.
Main Methods:
- Case-control study involving 27 VEO-UC patients.
- Human leukocyte antigen (HLA) typing using polymerase chain reaction-sequence-specific oligonucleotide probing (PCR-SSOP).
- Immunohistochemistry and fluorescence in situ hybridization to detect maternal microchimerism (MMc).
Main Results:
- Prevalence of HLA-B52 and HLA-DR15 was higher in VEO-UC cases compared to the general Japanese population.
- Maternal microchimerism (MMc) was detected in intestinal tissues of three VEO-UC patients.
- Maternal HLA concordance with VEO-UC associated alleles suggested maternal immune involvement.
Conclusions:
- VEO-UC shares genetic predispositions with adult UC, including associations with HLA-B52 and HLA-DR15.
- Maternal immune contributions, evidenced by MMc, play a role in VEO-UC pathogenesis.
- Further research is needed to develop targeted therapies for VEO-UC based on genetic and immunological mechanisms.
Background:
Very-early-onset ulcerative colitis (VEO-UC) is a severe form of inflammatory bowel disease that manifests before the age of 6 years. Compared to typical pediatric UC, it is characterized by distinct genetic and immunological factors. This study aimed to investigate the roles of specific human leukocyte antigen (HLA) alleles and maternal microchimerism (MMc) in the pathogenesis of VEO-UC in a Japanese population.
Methods:
This study included 27 VEO-UC patients, including 4 patients treated with colorectal resection. HLA typing was performed by polymerase chain reaction-sequence-specific oligonucleotide probing (PCR-SSOP) and compared with the Japanese general population. Immunohistochemistry and fluorescence in situ hybridization were used to evaluate MMc in intestinal tissues. Statistical comparisons of HLA were performed against data from the general Japanese population, with Bonferroni corrections applied to handle multiple comparisons.
Results:
HLA-B52 and HLA-DR15 were more prevalent in cases of VEO-UC than in the general Japanese population, although the statistical significance decreased after the Bonferroni correction. MMc was found in the intestinal tissues of three VEO-UC cases, whereas it was absent in the control UC cases. Maternal HLA concordance with specific alleles associated with VEO-UC was noted in several cases, suggesting maternal immune involvement in the pathogenesis of the disease.
Conclusions:
VEO-UC seems to share genetic traits with adult UC, such as an association with HLA-B52 and HLA-DR15, and is also affected by maternal immune contributions, as shown by the presence of MMc in the affected tissues. These findings highlight the complex interaction between genetic and immunological factors in the pathogenesis of VEO-UC and underscore the need for further research to develop targeted therapeutic strategies that address these mechanisms.
More Related Videos
Related Concept Videos
Development of Human Microbiota
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

